Literature DB >> 17632224

Association of acute symptoms and compliance attitude in noncompliant patients with schizophrenia.

Hong Liu-Seifert, John P Houston, David H Adams, Bruce J Kinon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17632224     DOI： 10.1097/01.jcp.0000264986.32733.df

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  7 in total

1.  Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission.

Authors:  Chen-Chung Liu; Huey-Ling Chiang; Szu-Ying Wu
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial.

Authors:  Douglas Faries; Haya Ascher-Svanum; Glenn Phillips; Allen W Nyhuis; Tomoko Sugihara; Virginia Stauffer; Bruce J Kinon
Journal:  BMC Med Res Methodol       Date:  2012-09-13       Impact factor: 4.615

3.  Patient perspectives on antipsychotic treatments and their association with clinical outcomes.

Authors:  Hong Liu-Seifert; Olawale O Osuntokun; Jenna L Godfrey; Peter D Feldman
Journal:  Patient Prefer Adherence       Date:  2010-10-05       Impact factor: 2.711

4.  Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians.

Authors:  Jian Chen; Haya Ascher-Svanum; Allen W Nyhuis; Michael G Case; Glenn A Phillips; Kory J Schuh; Vicki Poole Hoffmann
Journal:  Patient Prefer Adherence       Date:  2011-11-03       Impact factor: 2.711

5.  Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States.

Authors:  Nicolas M Furiak; Haya Ascher-Svanum; Robert W Klein; Lee J Smolen; Anthony H Lawson; Robert R Conley; Steven D Culler
Journal:  Cost Eff Resour Alloc       Date:  2009-04-07

6.  Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

Authors:  Leslie Citrome
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

7.  Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

Authors:  Hong Liu-Seifert; David H Adams; Haya Ascher-Svanum; Douglas E Faries; Bruce J Kinon
Journal:  Patient Prefer Adherence       Date:  2007-12-20       Impact factor: 2.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.